Staphylococcus aureus is often found in orthopaedic infections and may be protected from commonly prescribed antibiotics by forming biofilms or growing intracellularly within osteoblasts. To investigate the effect of non-antibiotic compounds in conjunction with antibiotics to clear intracellular and biofilm forming S. aureus causing osteomyelitis. SAOS-2 osteoblast-like cell lines were infected with S. aureus BB1279. Antibiotics (vancomycin, VAN; and dicloxacillin, DICLOX), bacterial efflux pump inhibitors (piperine, PIP; carbonyl cyanide m-chlorophenyl hydrazone, CCCP), and bone morphogenetic protein (BMP-2) were evaluated individually and in combination to kill intracellular bacteria. We present direct evidence that after gentamicin killed extracellular planktonic bacteria and antibiotics had been stopped, seeding from the infected osteoblasts grew as biofilms. VAN was ineffective in treating the intracellular bacteria even at 10Â MIC; however in presence of PIP or CCCP the intracellular S. aureus was significantly reduced. Bacterial efflux pump inhibitors (PIP and CCCP) were effective in enhancing permeability of antibiotics within the osteoblasts and facilitated killing of intracellular S. aureus. Confocal laser scanning microscopy (CLSM) showed increased uptake of propidium iodide within osteoblasts in presence of PIP and CCCP. BMP-2 had no effect on growth of S. aureus either alone or in combination with antibiotics. Combined application of antibiotics and natural agents could help in the treatment of osteoblast infected intracellular bacteria and biofilms associated with osteomyelitis. ß
Staphylococcus aureus is a gram-positive facultatively anaerobic bacterium and important pathogen in bone disease. It is responsible for about 70% of cases of osteomyelitis and 80% of joint infections in patients with rheumatoid arthritis and several other bone diseases. [1] [2] [3] [4] S. aureus infection of bone is associated with rapid, localized destruction of the tissue. Studies have reported the internalization of S. aureus by both epithelial and endothelial cells. 5, 6 Internalization of S. aureus by bone cells facilitates the progression of disease, by protecting the organism from extracellular host defenses and/or antibiotic therapy. This behavior could help explain the recurrent nature of diseases such as osteomyelitis in the absence of therapies that can kill intracellular bacteria.
Orthopaedic infections by S. aureus can relapse even after apparent clearance of the initial infection. It has been shown that bacteria causing infection can enter and reside within the osteoblast cells. The intracellular bacteria proliferate and colonize adjacent areas forming biofilm aggregates. These populations of intracellular bacteria and biofilms present a complicated clinical problem. [7] [8] [9] Antibiotics that are frequently used to treat S. aureus osteomyelitis include b-lactams, clindamycin, and fluoroquinolones. Vancomycin, dicloxacillin, linezolid, daptomycin, and fosfomycin are applied against resistant strains, such as MRSA. 6, 10, 11 Although rifampicin should not be used in monotherapy, several infection models and clinical studies have shown that it improves treatment outcomes when used in combination with other antibiotics. 12, 13 Antibiotics are generally used for the treatment of orthopaedic infections; however, in order to eliminate intracellular bacteria, high doses of the antibiotics would be required. Bacteria are known to develop antibiotic resistance following long term exposure to antibiotics; therefore, compounds that can synergistically improve the efficacy of antibiotics are needed.
We hypothesize that non-antibiotic compounds can be used to potentiate the antibacterial effect in presence of antibiotics. Therefore the non-antibiotic compounds, bone morphogenic protein (BMP-2) and the bacterial efflux inhibitors, piperine (PIP) and carbonyl cyanide m-chlorophenyl hydrazone (CCCP) were tested in conjunction with antibiotics dicloxacillin (DICLOX) and vancomycin (VAN) to clear intracellular bacteria found in osteomyelitis. PIP and CCCP have been reported to potentiate the efficacy of antibiotics by increasing permeability in S. aureus by inhibiting the bacterial efflux pumps. 14, 15 We therefore investigated whether these compounds could increase the permeability of osteoblasts so antibiotics can penetrate intracellularly and kill S. aureus. Moreover, BMP-2 has been shown to be effective in killing S. aureus in combination with vancomycin (Supplementary Information) and to increase the differentiation of osteoblast precursor cells. 16, 17 Therefore, whether antibiotics and non-antibiotic compounds, individually or in combination could potentially target intracellular S. aureus was studied. Moreover, we studied whether these compounds could lower the concentration of antibiotics that would be necessary to effectively kill intracellular S. aureus. Bacterial Culture and Growth Conditions S. aureus BB1279 was obtained from Dr. Alexander Horswill/ Blaise Boles, University of Iowa. S. aureus strain BB1279 was generated by electroporating the S. aureus LAC (MRSA USA300-0114) to constitutively produce green fluorescent protein (GFP). 18 The cells were grown in culture tubes containing 10 ml of Brain Heart Infusion broth (BHI). Tubes containing inoculated cells were placed on the shaker overnight. 1 ml of S. aureus cells were centrifuged at 10,000 rpm for 10 min. Supernatant was removed and the pellet was washed twice and re-suspended in PBS. The resulting solution was diluted (1:100 in PBS) and used for infectivity assay.
MATERIALS AND METHODS

Osteoblast
Antibiotics and Non-Antibiotics Agents
Gentamicin (GEN, Sigma-Aldrich, St. Louis, MO) was used to kill extracellular bacteria, while vancomycin (VAN, Sigma-Aldrich) and dicloxacillin (DICLOX, Sigma-Aldrich) antibiotics were used to test their efficacy against intracellular bacteria. The bacterial efflux pump inhibitor compounds piperine (PIP, Sigma-Aldrich), carbonyl cyanide m-chlorophenyl hydrazine (CCCP, Sigma-Aldrich), and bone morphogenic protein (BMP-2, Gibco) were used to determine their effect on killing of intracellular bacteria in combination with antibiotics VAN and DICLOX.
Determination of Minimum Inhibitory Concentrations (MIC) of Antibiotics and Non-Antibiotics
MIC for antibiotic and non-antibiotic agents was determined by microdilution method in 96-well plates. S. aureus (1 Â 10 6 cells/ml) was added to the antibiotic or non-antibiotics concentrations prepared in BHI in the 96-well plate, plates were incubated for 24 h and MIC was determined as the highest dilution with no growth of S. aureus. The MIC of gentamicin was determined to be 4 mg/ml. This concentration was used to determine the concentration for the gentamicin protection assay, in which extracellular bacteria are killed but intracellular cells are protected in eukaryotic cells, which are relatively impervious to aminoglycosides. The protected cells are then released by lysis for subsequent enumeration.
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Infectivity Assay S. aureus BB1279 cells were used to infect the HTB-85 osteoblast-like cells. S. aureus (1 Â 10 6 CFU) were added to the osteoblasts (1 Â 10 5 ) with the multiplicity of infection of 10. S. aureus cells were incubated with osteoblasts for 1 h at 37˚C. The osteoblast monolayer was washed three times with 1 ml PBS in each microwell to remove the non-adherent extracellular bacteria. Gentamicin (25 mg/ml; which was over 6Â the MIC) was added to each well and incubated at 37˚C for 3 h to kill the extracellular S. aureus in the gentamicin protection assay. 8, 20 Killing of extracellular bacteria was confirmed by performing the CFU counts on supernatants after treatment with gentamicin (data not shown). To estimate the infectivity of osteoblasts by S. aureus fluorescent microscopy was conducted, bacterial cells were detected by GFP.
Quantification of Intracellular S. aureus S. aureus infected osteoblast cells growing in micro-well plates were washed with 1 ml of PBS twice. The osteoblast cells were lysed to release intracellular S. aureus using 0.1% Triton X-100 (1 ml) for 20 min at 37˚C on ice with occasional rocking. The osteoblasts lysate was diluted and S. aureus cells were plated on BHI agar to quantify the number of bacteria. The lysate was centrifuged, cell free supernatant was washed with PBS twice, pellet was diluted with PBS in 96-well plate and 10 ml from each dilution was spotted onto sterile BHI agar plates. The plates were incubated overnight for growth of S. aureus at 37˚C and the bacterial colonies were counted and total colony forming units (CFU) were determined.
Killing of Intracellular Bacteria
Media from the three day infected osteoblasts containing well-plates was removed. Cell monolayer was washed twice with McCoy's media to remove any remaining GEN. 1 ml McCoy's medium was added along with the antibiotic and non-antibiotic compounds and incubated further for 24 h at 37˚C. Antibiotics (VAN, DICLOX) were used at 1Â and 10Â MIC concentrations and non-antibiotics (PIP, CCCP, and BMP-2) were used at 1Â MIC. The number of intracellular bacteria with and without treatment was estimated as mentioned above in the determination of intracellular S. aureus section. Infected osteoblasts without further drug treatment serve as control.
Effect of Bacterial Efflux Inhibitors on Osteoblast Cell Permeability
Efflux pump inhibitor compounds such as PIP and CCCP are known to increase permeability of bacterial cells to selected antibiotics. To determine whether these compounds also increase the permeability of osteoblasts in presence of antibiotics, confocal laser scanning microscopy (CLSM) using propidium iodide (PI, Molecular Probes) staining was performed. Osteoblasts were grown to confluence for 3 days in MatTek plates. Antibiotics and non-antibiotic agents were added and the plates were incubated for 24 h, and accumulation of propidium iodide was imaged using CLSM. Bacterial cells were not used in this assay.
Osteoblast Cell Viability and Cytotoxicity Assay
The effect of compounds on osteoblast cell viability was determined by measuring the WST-1 (Sigma-Aldrich) based colorimetric assay following the procedure mentioned by the TARGETING INTRACELLULAR Staphylococcus aureus supplier and previously reported. 21, 22 WST-1 [2-(4-Iodophenyl) -3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium salt] is used for quantification of cell proliferation, cell viability, and cytotoxicity measurement. 21, 22 Briefly, 1.5 Â 10 5 cells/cm 2 were seeded in 96-well microtiter plate wells and grown to confluency for 3 days. Chemical agents were added and the plates were incubated with WST-1 mixture for 2 h to quantitatively analyze the WST-1 activity as mentioned by the supplier. After this incubation period, the formazan dye formed is quantitated with a scanning multi-well spectrophotometer (ELISA reader). The measured absorbance directly correlates to the number of viable cells. Controls were wells containing osteoblasts without treatment with the chemical agents.
Statistical Analysis
All the experiments were performed in triplicates withAE SD. Statistically significant values (Students two tailed t-test, with equal variance) were considered for p < 0.05.
RESULTS
S. aureus Invades and Proliferates in Osteoblasts
S. aureus BB1279 infected the osteoblasts and extracellular planktonic bacteria were killed using GEN, however once the antibiotic pressure was removed, infected osteoblasts were allowed to grow for 3 days, intracellular bacterial cells proliferated from the infected osteoblasts, ruptured the osteoblasts, and released S. aureus that formed dense biofilms (Fig. 1) .
MIC of Compounds Against S. aureus
The MIC of antibiotics against S. aureus with VAN was 2 mg/ml; DICLOX, 0.125 mg/ml, and GEN 4 mg/ml, respectively while the non-antibiotics had MIC for BMP-2 as 0.1 mg/ml; PIP was 100 mg/ml and 2 mg/ml for CCCP, respectively.
Dicloxacillin is Effective Against Intracellular S. aureus DICLOX (10Â MIC) was able to significantly clear intracellular S. aureus (p < 0.01; Fig. 2 ) with by a 2 log reduction. VAN was ineffective in the treatment of intracellular S. aureus even at higher MIC concentrations (10Â MIC) ( Fig. 2A) . Fluorescent microscopic studies supported the reduction of intracellular S. aureus (by GFP labeling) after treatment with the antibiotic DICLOX than with VAN alone (Fig. 2B) . VAN (at 10Â MIC) was less effective in eliminating intracellular S. aureus than in combination with PIP or CCCP (Fig. 3) .
Efflux Pump Inhibitors Enhances the Efficacy of Antibiotics
We observed reduction in the number of intracellular bacteria in presence of antibiotics and efflux inhibitors. A decrease in the intracellular bacteria was observed with both PIP and CCCP. VAN (10Â MIC) in combination with CCCP, and VAN (10Â MIC) in combination with PIP (1Â MIC) showed significant inhibition (p < 0.01) of intracellular S. aureus. BMP-2 was not significant in killing the intracellular S. aureus present in osteoblasts (Fig. 4 ). Antibiotics at MIC had no effect on reducing the intracellular S. aureus. At 10Â MIC, significant elimination of both intracellular and extracellular S. aureus was observed. The efficacy of antibiotics was enhanced in presence of CCCP and PIP. VAN in combination with CCCP showed greater reduction ($3 log) in the number of intracellular bacteria than VAN þ PIP ($2 log) (Fig. 4) . Osteoblasts infected with S. aureus when treated with GEN for 3 h and antibiotics þ PIP and CCCP added showed $3 log reduction (p < 0.05) in the intracellular bacteria with DICLOX þ CCCP (Fig. 4) .
Increased Permeability Of Propidium Iodide (PI) in Osteoblasts
Propidium iodide (PI) is a fluorescent dye impermeable to the osteoblast cells due to its high molecular size. VAN is an extracellular antibiotic and impermeable to osteoblast cells, therefore could not reach high intracellular concentrations effective to kill the resident bacteria within osteoblast (Fig. 5D ). Compounds such as PIP or CCCP can enhance the permeability of osteoblasts to antibiotics and could be effective in killing intracellular bacteria. An increase in permeability was evidenced by uptake of the fluorescent PI stain in osteoblasts (Fig. 5A-R) . In the presence of PIP (Fig. 5P and R) and CCCP ( Fig. 5J and L) , accumulation of the red fluorescent PI was enhanced than without these compounds ( Fig. 5N  and H ). In combination with CCCP, DICLOX had higher cell permeability than PIP (Fig. 5L and R and Fig. 6 ).
Osteoblast Cell Viability Assay
The effect of compounds on cell viability was determined by WST-1 assay with SaOS-2 cells. The measured absorbance directly correlates to the number of viable cells. It was evident from Table 1 that viability of osteoblasts decreased after treatment with 1Â MIC of CCCP in combination with 10Â MIC of antibiotic DICLOX. PIP at 1Â MIC had no significant effect on reducing viability of osteoblasts when compared with CCCP. 
TARGETING INTRACELLULAR Staphylococcus aureus
DISCUSSION
S. aureus is a human pathogen causing significant morbidity and mortality in both community and hospital acquired infections. S. aureus frequently overcomes both host defense mechanisms and most antibiotic treatments. The purpose of the present study was to examine the effect of conventional antibiotics in conjunction with non-antibiotic compounds to reduce intracellular and biofilm associated growth of S. aureus infecting osteoblasts.
S. aureus is predominant bacterium in cases of orthopaedic infections. In a recent review, we have shown the role of bacterial biofilms, especially S. aureus in periprosthetic orthopaedic infections. 7 The bacterium can adhere to prosthetic components, fibrous tissues, and reside within the osteoblast cells. In the absence of antimicrobial agents, proliferation of intracellular bacteria takes place. These intracellular bacteria disrupt host cells, release, and can migrate to adjacent locations at the site of infection and forming biofilms. This study highlights extensive biofilm in absence of antibiotics by S. aureus that had infected osteoblasts (Fig. 1) .
S. aureus is often found in chronic and recurrent infections and could be responsible for such infections. The bacterium is believed to have developed several means to combat conventional antibiotic therapies, one of which is its ability to survive for long periods of time inside the host cells. 23 When used alone, some antibiotics (such as VAN) may not attain effective intracellular concentrations, effective in killing the resident bacteria within the osteoblast. Therefore, chemical agents that can increase the permeability of osteoblasts are needed. Bacterial efflux pump inhibitors have been studied for their efficacy to enhance permeability of antibiotics in bacterial cells. A recent study has also shown enhanced permeability of antibiotics, ciprofloxacin, and azithromycin in bacterial biofilms using the efflux pump inhibitor PIP and reserpine. 24 In the present study, our hypothesis was that these bacterial efflux pump inhibitors may be effective in improving the permeability of antibiotics within osteoblasts. To test this hypothesis, the fluorescent compound propidium iodide, which is impermeable to osteoblasts, was used. We have shown significant increase in the intracellular fluorescence due to accumulation of propidium iodide in osteoblasts in presence of PIP and CCCP (Figs. 5 and 6 ).
Reduction in intracellular S. aureus cells proved that combination of antibiotics (VAN or DICLOX) with PIP and/or CCCP improved killing of intracellular S. aureus compared with antibiotics alone. Differences in efficacy of VAN and DICLOX could be due to difference in targets or synergy with the nonantibiotic compounds. VAN has a higher molecular size that makes it impermeable to cells and therefore could be ineffective in the treatment of intracellular S. aureus. Our study highlights that high concentrations of VAN (at 10Â MIC) was ineffective in killing intracellular S. aureus. Therefore, instead of administration of high concentrations of VAN alone, lower concentrations of VAN in combination with efflux pump inhibitors such as PIP or CCCP could be beneficial in lowering infection. In addition, these compounds increase the permeability of osteoblasts, and antibiotics can enter the infected osteoblasts and can kill intracellular bacteria. Furthermore, CCCP and PIP are known to inhibit bacterial efflux. The osteoblast cytotoxicity result suggests that PIP may have advantages over CCCP in clinical application. Therefore, combination of antibiotic and efflux pump inhibitors could kill intracellular, extracellular, and biofilm bacterial population. The increase in inhibitory effect observed could allow clinicians to lower the concentration of antibiotic given to osteomyelitis patients, and this would help to slow the rise of antibioticresistant bacteria in the clinic. In conclusion, biofilms may form from infected intracellular S. aureus in the absence of antimicrobial agents. Antibiotic VAN (even at 10Â MIC) was ineffective in killing intracellular S. aureus present within osteoblasts. Therefore, application of chemical agents (PIP and/or CCCP) potentiates the efficacy of antibiotics by increasing permeability of antibiotics within osteoblasts, resulting in higher intracellular accumulation of antibiotics, and efficient killing of S. aureus. Combined application of antibiotics and natural compounds could therefore help in elimination of intracellular bacteria and biofilms associated with osteomyelitis.
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